|
CHAF1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.720320E-03 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
7.01161351202018E-12 |
| Stage1-vs-Stage2 |
2.536600E-03 |
| Stage1-vs-Stage3 |
5.112200E-01 |
| Stage1-vs-Stage4 |
7.518100E-02 |
| Stage2-vs-Stage3 |
2.064200E-03 |
| Stage2-vs-Stage4 |
6.008800E-04 |
| Stage3-vs-Stage4 |
2.542600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.01869999999493E-05 |
| Normal-vs-Asian |
8.18030088112209E-11 |
| Caucasian-vs-AfricanAmerican |
2.237000E-01 |
| Caucasian-vs-Asian |
7.981000E-01 |
| AfricanAmerican-vs-Asian |
4.059400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.761000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.36368694114708E-12 |
| Normal-vs-Age(81-100Yrs) |
3.727800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.768400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.396200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.051400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.087400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.687200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.389400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.221400E-03 |
| Classical-VS-Follicular |
6.40010044961059E-10 |
| Classical-VS-Other |
3.440600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.97180000502695E-08 |
| Tall-VS-Other |
9.882100E-02 |
| Tall-VS-Normal |
1.78934644878836E-12 |
| Follicular-VS-Other |
6.155800E-01 |
| Follicular-VS-Normal |
6.351600E-04 |
| Other-VS-Normal |
2.411400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.53740037262185E-10 |
| N0-vs-N1 |
1.760620E-01 |
|
|
